ViroGates offers free test kits to hospitals in Denmark to test potential COVID-19 patients 

More and more patients are presenting with respiratory symptoms, that may indicate coronavirus infection, at hospitals Emergency Departments.

In order to help Emergency Departments at Danish hospitals make faster and better decisions regarding who to send home, and who to admit to the hospital for care, ViroGates has decided to offer free suPARnostic® test kits to the Danish hospitals.

Read more

Optimize your emergency room flow

suPARnostic® is a prognostic inflammatory biomarker that reflects the level of activation of the human immune system. A low suPAR level indicates a good prognosis and supports the decision to discharge the patient.
A high suPAR level indicates presence, progression and severity of disease, organ damage and risk of mortality, and supports further clinical attention.
This enables you to make your clinical decision based on prognostic evidence.



Read More



Read More



Read More

Read our
latest news

Read our latest news in our Press Room regarding our products, our company, suPAR abstracts and presentations, conferences and congresses where you can find us etc.

See All
See All

Our Products

suPARnostic® is developed to measure the amount of suPAR protein (soluble urokinase Plasminogen Activator Receptor) in human blood.
It is the only CE-IVD certified product range applied for clinical determination of suPAR in human plasma and serum.
The suPARnostic® brand consists of the following 3 products:


For Automated Systems

See Product

Quick Triage Test

A Point of Care Solution

See Product


For Clinical and Research Use

See Product


Sign up to our newsletter and stay updated on suPAR